spacer
home > ebr > summer 2003 > the blossoming of biotechnology in wallonia
PUBLICATIONS
European Biopharmaceutical Review

The Blossoming of Biotechnology in Wallonia

R&D and entrepreneurship are closely linked. To be commercialised, R&D must be supported by entrepreneurial initiatives, and to make an initiative succeed, it needs to be based on competitive factors. R&D and biotechnology particularly have the potential to make a company highly competitive and bring strong added value.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Rudy Aernoudt, Deputy Head of Cabinet of the Walloon Ministry for Economy and Research

Rudy Aernoudt has studied Economics and Philosophy and holds a master's in European Economics. He was Special Adviser to the Belgian President of the Industry Council during the Belgian Presidency of the European Union.

As Deputy Head of Cabinet of the Walloon Ministry for Economy and Research, seconded by the European Commission, he deals with research, entrepreneurship and financing. He is also Professor in Corporate Finance at the business schools of Brussels, Ghent and Nancy. He has published books and articles on the topics of finance and politics.

spacer
Rudy Aernoudt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region. Government incentive schemes to increase domestic production, coupled with a brand friendly environment and rising healthcare needs is fuelling surging demand – with many new companies and plants launching in the last two years alone.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement